CLINICAL_TRIALS
trial_result
· 2024-04-24
Clinical Trial Update: A Trial to Determine the Efficacy and Safety of Presendin in IIH [Phase 3]
Summary
A Phase 3 trial investigating Presendin for idiopathic intracranial hypertension was terminated; results have been posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Invex Therapeutics Ltd. | Conditions: Idiopathic Intracranial Hypertension | Phase 3 | Status: TERMINATED | Results posted: 2024-04-24